Publication:
Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder

Simple item page
dc.contributor.authorHarirak Wanmuangen_US
dc.contributor.authorJuvady Leopairuten_US
dc.contributor.authorChomsri Kositchaiwaten_US
dc.contributor.authorWinai Wananukulen_US
dc.contributor.authorSukhum Bunyaratvejen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2018-08-24T02:11:51Z
dc.date.available2018-08-24T02:11:51Z
dc.date.issued2007-01-01en_US
dc.description.abstractHepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.90, No.1 (2007), 179-181en_US
dc.identifier.issn01252208en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-33847002316en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/25047
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33847002316&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleFatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powderen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33847002316&origin=inwarden_US

Files

Collections

Scopus 2006-2010